MicroRNA Childhood Cancer Catalog (M3Cs)

Publication Title	DOI	Year
MicroRNA expression in pediatric intracranial ependymomas and their potential value for tumor grading	https://doi.org/10.3892/ol.2018.9685	2018	Cell line 0 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 6 Master/Detail View
Transcriptomic analysis in pediatric spinal ependymoma reveals distinct molecular signatures-	https://doi.org/10.18632/oncotarget.23311	2017	Cell line 0 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 11 Master/Detail View
A microRNA profile of pediatric glioblastoma: The role of NUCKS1 upregulation	https://doi.org/10.3892/mco.2019.1795	2019	Cell line 0 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 6 Master/Detail View
Circulating microRNAs as Biomarkers for Pediatric Astrocytomas.	https://doi.org/10.1016/j.arcmed.2017.07.002	2017	Cell line 0 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 8 Master/Detail View
MicroRNA profile of pediatric pilocytic astrocytomas identifies two tumor-specific signatures when compared to non-neoplastic white matter.	https://doi.org/10.1007/s11060-018-03042-6	2018	Cell line 0 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 6 Master/Detail View
Identification of aberrant microRNA expression pattern in pediatric gliomas by microarray.	https://doi.org/10.1186/1746-1596-8-158	2013	Cell line 0 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 3 Master/Detail View
Genome-wide small noncoding RNA profiling of pediatric high-grade gliomas reveals deregulation of several miRNAs, identifies downregulation of snoRNA cluster HBII-52 and delineates H3F3A and TP53 mutant-specific miRNAs and snoRNAs.	https://doi.org/10.1002/ijc.29610	2015	Cell line 0 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 9 Master/Detail View
Integrated genomics has identified a new AT/RT-like yet INI1-positive brain tumor subtype among primary pediatric embryonal tumors.	https://doi.org/10.1186/s12920-015-0103-3	2015	Cell line 0 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 5 Master/Detail View
A proteomic approach of pediatric astrocytomas: MiRNAs and network insight.	https://doi.org/10.1016/j.jprot.2013.09.009	2013	Cell line 0 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 51 Master/Detail View
A proteomic approach of pediatric astrocytomas: MiRNAs and network insight.	https://doi.org/j.jprot.2013.09.009	2013	Cell line 0 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 1 Master/Detail View
Extensive miRNA expression analysis in craniopharyngiomas.	https://doi.org/10.1007/s00381-016-3131-1	2016	Cell line 0 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 27 Master/Detail View
Altered MicroRNA Expression Is Associated with Tumor Grade, Molecular Background and Outcome in Childhood Infratentorial Ependymoma.	https://doi.org/10.1371/journal.pone.0158464	2016	Cell line 0 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 4 Master/Detail View
Survey of MicroRNA Expression in Pediatric Brain Tumors	https://doi.org/10.1002/pbc.22723	2011	Cell line 0 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 3 Master/Detail View
Identification of microRNAs as potential prognostic markers in ependymoma.	https://doi.org/journal.pone.0025114	2011	Cell line 0 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 0 Master/Detail View
Identification of microRNA signature in different pediatric brain tumors.	https://doi.org/10.1590/1678-4685-GMB-2016-0334	2018	Cell line 0 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 19 Master/Detail View
miRNA expression profile of bone marrow resident cells from children with neuroblastoma is not significantly different from that of healthy children	https://doi.org/10.18632/oncotarget.24874	2019	Cell line 0 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 0 Master/Detail View
Identification of differentially expressed microRNAs by microarray: a possible role for microRNAs gene in medulloblastomas	https://doi.org/10.3760/cma.j.issn.0366-6999.2009.20.002	2009	Cell line 0 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 8 Master/Detail View
miR-141-3p and TRAF5 Network Contributes to the Progression of T-Cell Acute Lymphoblastic Leukemia.	https://doi.org/10.1177/0963689719887370	2019	Cell line 0 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 1 Master/Detail View
MicroRNA screening identifies circulating microRNAs as potential biomarkers for osteosarcoma	https://doi.org/10.3892/ol.2015.3378	2015	Cell line 0 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 7 Master/Detail View
Clinical significance of microRNA-34b expression in pediatric acute leukemia	https://doi.org/10.3892/mmr.2016.4876	2016	Cell line 0 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 2 Master/Detail View

Publications